Listed

Celularity Inc

CELUNasdaqCIK 1752828HealthcareFiscal year ends Dec 31

Reports and events: 186 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Celularity Inc, Reports and events
FiledFormWhat it isAccession number
2025-04-2317:15 ET8-K3.01 Delisting notice0001641172-25-005884
2025-03-2116:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-25-011156
2025-02-2409:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-007986
2025-02-1808:45 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-25-007097
2025-02-1306:20 ETS-1/ARegistration statement, amended0001493152-25-006219
2025-01-3017:31 ETS-1Registration statement0001493152-25-004313
2025-01-2816:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0001140361-25-002203
2025-01-2709:00 ET8-K1.01 Entry into a material agreement0001493152-25-003722
2025-01-2417:17 ET8-K1.02 Termination of a material agreement0001493152-25-003635
2025-01-0317:20 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-25-000294
2024-12-2008:00 ET8-K5.07 Shareholder vote results0001493152-24-050885
2024-12-1921:16 ETSCHEDULE 13D/AOwnership report, active investor, amended0001140361-24-049987
2024-12-0619:45 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-133799
2024-12-0217:27 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-24-048330
2024-11-2921:08 ET8-K3.01 Delisting notice0001493152-24-048082
2024-11-1916:15 ETDEF 14AProxy statementPeriod 2024-10-190001493152-24-046819
2024-11-0816:30 ET8-K8.01 Other events0001493152-24-044292
2024-11-0708:10 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-043924
2024-11-0717:33 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-122493
2024-10-2516:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-042525
2024-10-2107:24 ET8-K3.01 Delisting notice0001493152-24-041706
2024-10-1617:25 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-115082
2024-10-1617:20 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-041330
2024-09-1317:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-24-036234
2024-08-2817:23 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-034216
2024-08-2317:15 ET8-K3.01 Delisting notice0001493152-24-033763
2024-08-0517:15 ET8-K4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-24-030288
2024-07-3016:26 ET10-KAnnual reportPeriod 2023-12-310000950170-24-087886
2024-05-2417:15 ET8-K3.01 Delisting notice0001493152-24-021404
2024-05-2109:25 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-020832
2024-04-2206:05 ET8-K3.01 Delisting notice0001493152-24-015455
2024-03-1517:32 ETSC 13D/AOwnership report, active investor, amended0001140361-24-013586
2024-03-1517:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001493152-24-010134
2024-02-2617:15 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-007848
2024-02-2209:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-24-007505
2024-02-1216:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-005900
2024-02-0206:01 ETDEF 14AProxy statementPeriod 2024-02-020001493152-24-004649
2024-01-1717:15 ETSC 13D/AOwnership report, active investor, amended0001140361-24-002583
2024-01-1716:14 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-24-005029
2024-01-0916:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-003387
2024-01-0321:12 ET10-QQuarterly reportPeriod 2023-09-300000950170-24-000474
2023-12-2916:47 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-073894
2023-11-2413:46 ET8-K3.01 Delisting notice0001193125-23-282722
2023-09-1909:25 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events0000950170-23-048663
2023-09-0716:21 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-047017
2023-08-2909:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-044896
2023-08-2516:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-23-221469
2023-08-1417:24 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-042544
2023-08-0416:16 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-038577
2023-07-2816:27 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-197738

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.